Serum Endocan Levels and Gestational Diabetes

NCT05237895 | Completed DMC

• 1 other identifier: GaziosmanpaşaTREHi
• Study Type: interventional
• Target: 90
• Locations: 1 country
• Sites: 1

Brief Summary

In diabetic patients, serum endocan level has been significantly increased in patients and the levels on the long-term complications are correlated. Based on the Iinformation obtained from these studies, it can be said that there is a strong association between diabetes and serum endocan levels.

Conditions

Gestational Diabetes; Endocan

Outcome Measures

Primary Outcomes (1)

• Detection of diagnostic value of serum endocan levels in patient with gestational diabetes

  Identifying diagnostic value of serum endocan by comparing serum levels of endocan in groups.

  3 months

Study Arms (2)

Patients with Gestational Diabetes

OTHER

pregnant women who are at 24-26 weeks of gestational age with positive oral glucose tolerance screening test.

Diagnostic Test: Serum Endocan Levels

Healty Pregnants

OTHER

pregnant women who are at 24-26 weeks of gestational age with normal oral glucose tolerance screening test.

Diagnostic Test: Serum Endocan Levels

Interventions

Serum Endocan Levels DIAGNOSTIC_TEST

Detection of Serum Endocan Levels and detection of possible diagnostic association with gestational diabetes

Healty Pregnants; Patients with Gestational Diabetes

Eligibility Criteria

• Age: 18 Years - 45 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• being pregnant at 24-26 weeks of gestation
• having oral glucose toleranse screening test
• age between 18-45 years

You may not qualify if:

• having in utero mort fetus
• having a previous diagnosis of diabetes
• having a multiple pregnancy
• having a coronary artery disease
• having preeclampcia
• having a pregnancy obtained by assisted reproductive technology
• using cigarette
• using alcohol

Sponsors & Collaborators

• Gaziosmanpasa Research and Education Hospital: lead

Study Sites (1)

Gaziosmanpaşa Treh

Istanbul, Gaziosmanpaşa, 34000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy Complications; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Study Officials

• elif yıldız, MD

  Gaziosmanpasa Research and Education Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: February 3, 2022
• First Posted: February 14, 2022
• Study Start: March 3, 2022
• Primary Completion: May 5, 2022
• Study Completion: May 5, 2022
• Last Updated: August 5, 2022

Record last verified: 2022-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)